🟢 Protara Therapeutics is trading 10.25% up today with no clear catalyst identified

Protara Therapeutics is trading 10.25% up at $3.87 after rising from the September 21 close of $3.51.

• No clear company-specific catalyst has been identified for the September 22, 2026 move.
• A same-day analysis noted $142 million in cash, no debt, and approximately 2.1 years of runway, but did not connect those details to the increase.
• Broader markets are mixed, leaving the gain unexplained.